Study2023

Associations of dietary cholesterol and fat, blood lipids, and risk for dementia in older women vary by APOE genotype

Dunk MM, Li J, Liu S, Casanova R, Chen JC, Espeland MA, Hayden KM, Manson JE, Rapp SR, Shadyab AH, Snetselaar LG, Van Horn L, Wild R, Driscoll I

Alzheimer's & dementia : the journal of the Alzheimer's Association · 42 citations

Review labels

No stated lifestyle adjustment

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Cohort study (classified by our AI screen)
Studied in
People
Main outcome
Clinical events such as disease or death
Intake measured by
Not stated

Who paid for it

Funding
Independent funding
Government
U.S. Department of Health and Human Services
Government
Women's Health Initiative
University or hospital
University of Wisconsin-Milwaukee
Government
National Institutes of Health
Government
National Institute on Aging
Government
National Heart, Lung, and Blood Institute
Government
NIA NIH HHS
Government
NHLBI NIH HHS
Grants
National Institute on Aging (R01AG074345); National Heart, Lung, and Blood Institute (HHSN268201600018C); National Institute on Aging (HHSN-271-2011-00004C,); National Heart, Lung, and Blood Institute (HHSN268201600004C); National Heart, Lung, and Blood Institute (HHSN268201600001C); National Heart, Lung, and Blood Institute (HHSN271201100004C); National Institute on Aging (P30 AG072947); U.S. Department of Health and Human Services (HHSN-271-2011-00004C); National Institute on Aging (RF1 AG079149); National Institute on Aging (RF1 AG074345); National Heart, Lung, and Blood Institute (HHSN268201600003C); National Heart, Lung, and Blood Institute (HHSN268201600002C)

Based on 8 listed funder(s).

Publication

Published
2023-07-12 · Alzheimers Dement · vol. 19 · issue 12 · pp. 5742–5754
Publisher
Wiley
Cited
51 citations · more than 98% of similar papers · 6.9× the field average
Impact
Top 10% most cited in its field
References
52 works
Access
Open access (hybrid journal) · CC-BY-NC
Research areas
Alzheimer's disease research and treatments · Nutritional Studies and Diet · Dementia and Cognitive Impairment Research
Keywords
Dementia, Apolipoprotein E, Mendelian randomization, Internal medicine, Cholesterol, Odds ratio, Blood lipids, Lipoprotein, Endocrinology, Medicine, Risk factor, Gerontology, Biology, Disease, Genotype, Biochemistry
MeSH
humans, dementia, cholesterol, cholesterol, dietary, triglycerides, apolipoproteins e, risk factors, genotype, aged, female, apolipoprotein e4

14 authors

From SE, US, CN

  • Michelle M. DunkKarolinska Institutet; University of Wisconsin–Milwaukee
  • Jie LiRhode Island Department of Health; Brown University; Guangdong Academy of Medical Sciences; Guangdong Provincial People's Hospital
  • Simin LiuRhode Island Department of Health; Brown University
  • Ramon CasanovaWake Forest University
  • Jiu‐Chiuan ChenUniversity of Southern California
  • Mark Andrew EspelandWake Forest University

Abstract

Introduction

Whether apolipoprotein E's (APOE's) involvement in lipid metabolism contributes to Alzheimer's disease (AD) risk remains unknown.

Methods

Incident probable dementia and cognitive impairment (probable dementia+mild cognitive impairment) were analyzed in relation to baseline serum lipids (total, low-density lipoprotein [LDL], high-density lipoprotein [HDL], non-HDL cholesterol, total-to-HDL, LDL-to-HDL, remnant cholesterol, and triglycerides) using Mendelian randomization in 5358 postmenopausal women from the Women's Health Initiative Memory Study. We also examined associations of baseline dietary cholesterol and fat with lipids based on APOE status.

Results

After an average of 11.13 years, less favorable lipid levels related to greater dementia and cognitive impairment risk. Dementia (odds ratio [OR] = 3.13; 95% confidence interval [CI]: 2.31 to 4.24) and cognitive impairment (OR = 2.38; 95% CI: 1.85 to 3.06) risk were greatest in relation to higher remnant cholesterol levels. Greater cholesterol consumption related to poorer lipids in APOE4+ compared to APOE3 carriers.

Discussion

APOE4+ carriers consuming more cholesterol had less favorable lipids, which were associated with greater dementia and cognitive impairment risk.

Highlights

Less favorable serum lipids were associated with higher dementia incidence. Mendelian randomization findings suggest causality between lipids and dementia. Lipid levels in older women may be clinical indicators of dementia risk. APOE4 carriers had poorest lipid profiles in relation to cholesterol consumption. APOE risk for dementia may be modifiable through lipid management.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.